Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P22304: Variant p.Asn63Asp

Iduronate 2-sulfatase
Gene: IDS
Feedback?
Variant information Variant position: help 63 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Asparagine (N) to Aspartate (D) at position 63 (N63D, p.Asn63Asp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (N) to medium size and acidic (D) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In MPS2; mild/intermediate form. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 63 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 550 The length of the canonical sequence.
Location on the sequence: help IVDDLRPSLGCYGDKLVRSP N IDQLASHSLLFQNAFAQQAV The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         IVDDLRPSLGCYGDKLVRSPNIDQLASHSLLFQNAFAQQAV

Mouse                         IVDDLRPSLGCYGDKLVRSPNIDQLASHSVLFQNAFAQQAV
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 34 – 455 Iduronate 2-sulfatase 42 kDa chain
Binding site 45 – 45
Binding site 46 – 46
Helix 62 – 69



Literature citations
Mucopolysaccharidosis type II (Hunter syndrome): mutation 'hot spots' in the iduronate-2-sulfatase gene.
Rathmann M.; Bunge S.; Beck M.; Kresse H.; Tylki-Szymanska A.; Gal A.;
Am. J. Hum. Genet. 59:1202-1209(1996)
Cited for: VARIANTS MPS2 ASP-63; THR-85; GLN-86; CYS-88; HIS-88; CYS-108; SER-117 DEL; VAL-125; ARG-134; PHE-184; ASN-252; LEU-333; ILE-347; ARG-403 AND GLN-468; Mutation analysis in 20 patients with Hunter disease.
Goldenfum S.L.; Young E.; Michelakakis H.; Tsagarakis S.; Winchester B.;
Hum. Mutat. 7:76-78(1996)
Cited for: VARIANTS MPS2 ASP-63; ARG-86; GLY-95; PRO-205; TRP-468 AND GLN-468; Mucopolysaccharidosis type II: identification of six novel mutations in Italian patients.
Villani G.R.D.; Balzano N.; Grosso M.; Salvadore F.; Izzo P.; di Natale P.;
Hum. Mutat. 10:71-75(1997)
Cited for: VARIANTS MPS2 ASP-63; THR-347; GLN-468 AND LEU-468; Mutational spectrum of the iduronate-2-sulfatase (IDS) gene in 36 unrelated Russian MPS II patients.
Karsten S.; Voskoboeva E.; Tishkanina S.; Pettersson U.; Krasnopolskaya X.; Bondeson M.-L.;
Hum. Genet. 103:732-735(1998)
Cited for: VARIANTS MPS2 ASP-54; ASP-63; GLU-79; CYS-88; LEU-88; HIS-88; ARG-102; PRO-159; SER-196; GLY-198; GLU-224; LEU-333; ASP-340; TYR-432; GLN-468; TYR-478 AND ARG-485;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.